Pol S, Thompson AJ, Collins M, Venier E, et al. Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study. Hepatology 2024 May 20. doi: 10.1097/HEP.0000000000000923.
PMID: 38768260